Pullback Status: Watching Horizontal S&R: yes, Weekly Channel S&R: no MA S&R: no Stochastic turn/crossover above 80%: no AO pullback >0= 85: yes Price Pullback Fib >0.382: yes Next Earnings date: Increasing EPS: ok Increasing Rev: missed *stop 1 atr below swing low. ** first price target is 50% the move from entry price to previous high. ***No Biotech Any...
Status: neutral Update: Due to recent volatility and weakness I will not even try going long except on time frames >= daily Using 60min for early entry.
Double Bottom Status: Closed Long Horizontal S&R: monthly Channel S&R: yes MA S&R: no Stochastic turn/crossover above 80%: no AO divergence >0= 85: yes Price Fib Ext >1.382: yes Next Earnings date: 8/19/14 Increasing EPS: no - missed Increasing Rev: no - missed www.estimize.com *stop 1 atr below swing low. ** first price target is 50% the move from entry...
Status: Long Cost Basis: 50.00 Horizontal S&R: monthly Channel S&R: monthly MA S&R: no Stochastic turn/crossover above 80%: no AO pullback >0= 85: yes Price Pullback Fib >0.382: Next Earnings date: Sep 23, 2014 (EST) Increasing EPS: yes - beat Increasing Rev: yes - beat www.estimize.com *stop 1 atr below swing low. ** first price target is 50% the move...
Status: Watchlist Horizontal S&R: yes Channel S&R: yes MA S&R: no Stochastic turn/crossover above 80%: yes AO divergence >0= 85: yes Price Fib Ext >1.382: yes Next Earnings date: 7/30 Increasing EPS: tmrw Increasing Rev: tmrw *stop 1 atr below swing low. ** first price target is 50% the move from entry price to previous high. ***No Biotech Any feedback...
Clearly CAB made a nice double top confirmed by the AO. Now is CAB going to make a double bottom here? I don't think so for two reasons. 1. AO not showing any divergence and 2. the double top price target is closer to 52. For those who are long, I hope I'm wrong. Horizontal S&R: yes Channel S&R: no MA S&R: no Stochastic turn/crossover above 80%: yes AO pullback ...
Update: GWPH holding up ok considering this market sucks, but will tighten stop to pivot low. Get in later again if stopped. Horizontal S&R: no Channel S&R: yes MA S&R: yes Stochastic turn/crossover above 80%: yes AO pullback >0= 85: yes Price Pullback Fib >0.382: yes Next Earnings date: n/a Increasing EPS: Increasing Rev: *stop 1 atr below swing...
Horizontal S&R: yes, weekly Channel S&R: yes MA S&R: no Stochastic turn/crossover above 80%: yes AO divergence >0= 85: yes Price Fib Ext >1.382: yes Next Earnings date: Jul 30, 2014 (EST) Increasing EPS: no Increasing Rev: no Short Float: 35% *stop 1 atr below swing low. ** first price target is 50% the move from entry price to previous high. ***No...
Horizontal S&R: no Channel S&R: yes MA S&R: no Stochastic turn/crossover above 80%: no AO pullback >0= 85: yes Price Pullback Fib >0.382: yes Increasing EPS: yes Increasing Rev: yes *stop 1 atr below swing low. ** first price target is 50% the move from entry price to previous high. ***No Biotech
Horizontal S&R: no Channel S&R: no MA S&R: no Stochastic turn/crossover above 80%: looks embedded AO pullback >0= 85: ys Price Pullback Fib >0.382: n/a Increasing EPS: yes, but expectations missed Increasing Rev: yes *stop 1 atr below swing low. ** first price target is 50% the move from entry price to previous high. ***No Biotech
Horizontal S&R: no Channel S&R: yes MA S&R: no Stochastic turn/crossover above 80%: starting to become embedded AO pullback >0= 85: no Price Pullback Fib >0.382: n/a Increasing EPS: beat Increasing Rev: no *stop 1 atr below swing low. ** first price target is 50% the move from entry price to previous high. ***No Biotech
Horizontal S&R: in between 65 and 67. Channel S&R: breaking MA S&R: breaking Stochastic turn/crossover above 80%: good AO pullback >0= 85: no Price Pullback Fib >0.382: n/a Increasing EPS: no Increasing Rev: no *stop 1 atr below swing low. ** first price target is 50% the move from entry price to previous high. ***No Biotech
200 may serve as magnet could be forming divergence on AO
Horizontal S&R: yes weekly Channel S&R: breaking above weekly MA S&R: closed above 50 daily Stochastic turn/crossover above 80%: yes AO pullback >0= 85: yes Price Pullback Fib >0.382: yes Increasing EPS: no (in line) Increasing Rev: yes (actually beat for first time in years) *stop 1 atr below swing low. ** first price target is 50% the move from entry...
Horizontal S&R: yes Channel S&R: yes MA S&R: no Stochastic turn/crossover above 80%: yes AO pullback >0= 85: ok Price Pullback Fib >0.382: yes Increasing EPS: yes Increasing Rev: yes *stop 1 atr below swing low. ** first price target is 50% the move from entry price to previous high. ***No Biotech